Gene therapy recipients monitored for hidden risks
Knowledge-focused
Ongoing
This study follows 11 people who previously received an experimental HIV gene therapy called Cal-1. The main goal is to watch for any delayed side effects from the treatment. Researchers will also check how long the modified cells survive in the body. No new treatment is given; t…
Sponsor: Calimmune, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC